An example of a situation that human could suffer from his own innovations in the field of medicine is the case involving a drug called TGN1412 in England, where 6 lives were threatened in March 2006. This incident highlighted ethical issues in clinical study design and safety monitoring.
The main stakeholders in the case given include the StarAlpha Medicines, with its research and Development Department directly involved, and Country X with the direct participation of its citizen specifically the poor women who will be the potential subjects of the clinical trials to be carried out. StarAlpha Medicines could benefit a lot if the CEO's suggestion will materialize. The said pharmaceutical company, as the future main distributor of the drugs being developed, will be able to achieve skyrocketing sales. Also, if the strict procedures in clinical trials being observed in Europe will not be followed and taken for granted, instead it will be carried out in country X where a more favorable conditions for clinical trial are offered, it will be an effective mean of cost-cutting on the part of the pharmaceutical company - less expense but big revenues.
Country X on the other hand, will reap both the positive effects and the possible negative outcome of the test. If the drug will be administered to poor, sick women, and the result will be successful, then Country X has found a cheap and easy way of providing treatment to its sick citizens. However, if the wellness and safety of the women to be subjected to the study will be overlooked, instead of being recipients of good health and a cure to their illness, they will be exposed to potential and real health risks. It could be possible that their health will be more endangered or that their system could possibly develop a negative response to the drugs which could then end to severe complications. Administering the drug without following a strict procedure in taking the needed test for its effectiveness and safety could be reasons for overlooking important concerns to its effects to the human body. A series of physiological reactions could take place beyond the control and knowledge of the pharmaceutical industry. Problems not anticipated by the Research Department will be to the expense of the patients' welfare, the poor citizens desperate for cure to their illness are the ones who are always at risk, the ones who will mostly suffer the consequences of irresponsible clinical trials. Clinical trials, obviously subject human life into studies with the objectives that meaningful outcome will be achieved or for hypothesis being tested to be proven or disprove. These trials involve people - it could be a mother with kids leaning on her, a father with a family depending on him, or a boy who spends his day in the hospital bed when he should have a cheerful and sunny day in the park. These subjects are people with hearts that beat, with life worthy of utmost respect. And so, that's why ethics in the practice of medicine need to be of important considerations.
Ethical considerations could be influenced by philosophical, religious, moral or legal perspectives and beliefs. In the conduct of clinical trials, one of the important elements to be